RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

Regulatory Focus™ > News Articles > FDA Approval of Botanical Drugs

FDA Approval of Botanical Drugs

Posted 01 January 2009 | By Max Sherman 

The US Food and Drug Administration (FDA) defines a botanical drug as a product used as a drug that contains as ingredients vegetable materials, which may include plant materials, algae, macroscopic fungi or combinations thereof. Unfortunately, active ingredients found in botanical products are difficult to characterize, as are the methods to measure their potency. Moreover, the composition of vegetable materials can vary from season to season and farm to farm. Most botanical drugs are complex mixtures and may lack a distinct active ingredient. For these reasons, the agency historically paid little heed to or generally neglected any form of herbal medicine.1

Regulatory Focus newsletters

All the biggest regulatory news and happenings.


Regulatory Focus™ is doing essential, non-biased journalism during this unprecedented time. We appreciate your support as we bring you the news and intelligence you need to make an impact on global healthcare.

Regulatory Focus™ provides the intelligence you need to impact global healthcare during this crisis. Thank you for your support.